These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Hamilton TC; Winker MA; Louie KG; Batist G; Behrens BC; Tsuruo T; Grotzinger KR; McKoy WM; Young RC; Ozols RF Biochem Pharmacol; 1985 Jul; 34(14):2583-6. PubMed ID: 4040369 [No Abstract] [Full Text] [Related]
3. Glutathione depletion in tissues after administration of buthionine sulphoximine. Minchinton AI; Rojas A; Smith KA; Soranson JA; Shrieve DC; Jones NR; Bremner JC Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1261-4. PubMed ID: 6469748 [TBL] [Abstract][Full Text] [Related]
4. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow. Ono K; Shrieve DC J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662 [TBL] [Abstract][Full Text] [Related]
5. Intracellular glutathione as a determinant of responsiveness to antitumor drugs. Romine MT; Kessel D Biochem Pharmacol; 1986 Oct; 35(19):3323-6. PubMed ID: 3464280 [TBL] [Abstract][Full Text] [Related]
6. Anthracycline resistance in murine leukemic P388 cells. Role of drug efflux and glutathione related enzymes. Nair S; Singh SV; Samy TS; Krishan A Biochem Pharmacol; 1990 Feb; 39(4):723-8. PubMed ID: 2306280 [TBL] [Abstract][Full Text] [Related]
7. Compartmentalised depletion of glutathione in cells treated with buthionine sulphoximine. Edgren M; Révész L Br J Radiol; 1987 Jul; 60(715):723-4. PubMed ID: 3620835 [No Abstract] [Full Text] [Related]
8. Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard. Somfai-Relle S; Suzukake K; Vistica BP; Vistica DT Biochem Pharmacol; 1984 Feb; 33(3):485-90. PubMed ID: 6704165 [No Abstract] [Full Text] [Related]
9. Toxic effects of extended glutathione depletion by buthionine sulfoximine on murine mammary carcinoma cells. Dethlefsen LA; Biaglow JE; Peck VM; Ridinger DN Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1157-60. PubMed ID: 3744934 [TBL] [Abstract][Full Text] [Related]
10. Subcellular glutathione contents in isolated hepatocytes treated with L-buthionine sulfoximine. Romero FJ; Sies H Biochem Biophys Res Commun; 1984 Sep; 123(3):1116-21. PubMed ID: 6487323 [TBL] [Abstract][Full Text] [Related]
11. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation. Shrieve DC; Harris JW Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936 [TBL] [Abstract][Full Text] [Related]
12. The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice. Ishikawa M; Takayanagi Y; Sasaki K Jpn J Pharmacol; 1990 Apr; 52(4):652-5. PubMed ID: 2342233 [TBL] [Abstract][Full Text] [Related]
13. Reversal of melphalan resistance in vivo and in vitro by modulation of glutathione metabolism. Medh RD; Gupta V; Awasthi YC Biochem Pharmacol; 1991 Jul; 42(2):439-41. PubMed ID: 1859455 [No Abstract] [Full Text] [Related]
14. Marked reduction of rat brain glutathione following intracerebroventricular administration of the glutathione synthesis inhibitor L-buthionine sulfoximine. Pileblad E; Magnusson T Neurosci Lett; 1988 Dec; 95(1-3):302-6. PubMed ID: 3226616 [No Abstract] [Full Text] [Related]
15. [Increasing chemosensitivity to cisplatin by glutathione depletion with buthionine sulfoximine. In vitro and in vivo studies with a human squamous cell cancer line]. Bier H Laryngorhinootologie; 1990 Jan; 69(1):16-20. PubMed ID: 2310456 [TBL] [Abstract][Full Text] [Related]